MustGrow Biologics Corp.
MGROF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $398 | $4,712 | $6 | $13 |
| % Growth | -91.6% | 72,627.3% | -49.7% | – |
| Cost of Goods Sold | $97 | $385 | $298 | $204 |
| Gross Profit | $301 | $4,328 | -$292 | -$191 |
| % Margin | 75.6% | 91.9% | -4,506.9% | -1,484.2% |
| R&D Expenses | $774 | $857 | $476 | $458 |
| G&A Expenses | $3,349 | $3,123 | $3,788 | $1,512 |
| SG&A Expenses | $3,819 | $3,681 | $4,485 | $2,080 |
| Sales & Mktg Exp. | $470 | $559 | $697 | $568 |
| Other Operating Expenses | $822 | $979 | $731 | $487 |
| Operating Expenses | $5,415 | $5,517 | $5,692 | $3,024 |
| Operating Income | -$5,114 | -$805 | -$5,685 | -$3,011 |
| % Margin | -1,284.9% | -17.1% | -87,745% | -23,397.3% |
| Other Income/Exp. Net | $225 | $128 | $119 | -$51 |
| Pre-Tax Income | -$4,889 | -$677 | -$5,566 | -$3,064 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,889 | -$677 | -$5,566 | -$3,064 |
| % Margin | -1,228.3% | -14.4% | -85,908.3% | -23,809.2% |
| EPS | -0.095 | -0.014 | -0.11 | -0.07 |
| % Growth | -596.3% | 87.6% | -56.9% | – |
| EPS Diluted | -0.095 | -0.014 | -0.11 | -0.07 |
| Weighted Avg Shares Out | 51,596 | 49,896 | 49,010 | 43,736 |
| Weighted Avg Shares Out Dil | 51,596 | 49,895 | 49,010 | 43,736 |
| Supplemental Information | – | – | – | – |
| Interest Income | $202 | $212 | $104 | $3 |
| Interest Expense | $0 | $0 | $10 | $53 |
| Depreciation & Amortization | $4,513 | $211 | $5,252 | $2,729 |
| EBITDA | -$601 | -$466 | -$304 | -$282 |
| % Margin | -151% | -9.9% | -4,692.1% | -2,191.3% |